Nose Diseases: Clinical Trials

5 trials for Nose Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 active not recruiting. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Active not recruiting 5

Follow Nose Diseases: new trials by email Literature Review of Nose Diseases trials Research Report on Nose Diseases

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
INTRANASAL FLUTICASONE VERSUS FLUTICASONE-AZELASTINE COMBINATION
Fluticasone propionate nasal spray, Fluticasone propionate-azelastine nasal spray - Allergic Rhinitis
Phase 4Active not recruitingPamukkale University612022-12-012026-02-17
Dupixent Study for Alternate Administration
Dupilumab - Nasal Polyps, Sinusitis
Phase 4Active not recruitingMadigan Army Medical Center302021-10-142025-01-17
Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
Montelukast, Placebo - Meniere Disease, Allergic Rhinitis
Phase 4Active not recruitingHouse Ear Institute392021-06-072025-03-18
Epigenetic Health Benefits of Budesonide
Budesonide Nasal, Placebo - Epigenetic Effects of Intranasal Steroids, Environmental Exposure
Phase 4Active not recruitingUniversity of British Columbia202021-01-072025-03-27
Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients with CRS
Celecoxib, Placebo - Chronic Rhinosinusitis with Nasal Polyps, Aspirin-exacerbated Respiratory Disease
Phase 4Active not recruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's442020-02-182024-10-29

Narrower conditions

Rhinitis, Allergic (3)  ·  Nasal Polyps (2)  ·  Agnosia (1)  ·  Chronic Disease (1)  ·  Meniere Disease (1)  ·  Sinusitis (1)  ·  Vertigo (1)

Broader conditions

Otorhinolaryngologic Diseases (5)  ·  Respiratory Tract Diseases (5)  ·  Hypersensitivity (3)  ·  Hypersensitivity, Immediate (3)  ·  Immune System Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Respiratory Hypersensitivity (3)  ·  Rhinitis (3)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Anatomical (2)  ·  Polyps (2)  ·  Signs and Symptoms (2)  ·  Disease Attributes (1)

Interventions

Budesonide (1)  ·  Celecoxib (1)  ·  dupilumab (1)  ·  montelukast (1)

Sponsors

House Ear Institute (1)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)  ·  Madigan Army Medical Center (1)  ·  Pamukkale University (1)  ·  University of British Columbia (1)

Countries

Canada (2)  ·  United States (2)  ·  Saudi Arabia (1)  ·  Turkey (Türkiye) (1)

Top investigators

Christopher Carlsten, MD (1)  ·  Leigh Sowerby, MD (1)  ·  Mary J Derebery, MD (1)  ·  Renee M Serra, MD (1)  ·  Roy F Thomas, MD (1)

Results publications

PMID 41759721